Our name has changed!
Sagimet Biosciences better reflects our expertise in fatty acid metabolism and current focus on developing ground-breaking therapeutics to treat the liver disease NASH.
Continue to Sagimet
About
Overview
Senior Management
Board of Directors
Scientific advisors
Careers
Science
FASN
Posters/Publications
News
Press Releases
Programs
Overview
Pipeline
Contact